tm logo
FLICKER PHARMS
Dead/Abandoned
ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE

failure to respond or late response

on 22 Mar 2024

Last Applicant/ Owned by

524 Flicker Ave

Longmont

CO

80501

Serial Number

97465217 filed on 18th Jun 2022

Registration Number

N/A

Correspondent Address

Longmont,CO 80501

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

FLICKER PHARMS

Neutraceuticals: specifically adaptogens, nootropics, vitamins, supplements, and minerals in the forms of; tinctures, topicals, beverages, capsules, gummies, tablets, and powder; Consumer Packaged Goods specifically, bath salts, bath bombs, topicals, facial creams and moisturizers, body creams, and oils

Classification Information


Class [005]
Pharmaceutical Products


Neutraceuticals: specifically adaptogens, nootropics, vitamins, supplements, and minerals in the forms of; tinctures, topicals, beverages, capsules, gummies, tablets, and powder; Consumer Packaged Goods specifically, bath salts, bath bombs, topicals, facial creams and moisturizers, body creams, and oils


First Use Date in General

01st Apr 2022

First Use Date in Commerce

01st Jun 2022

Mark Details


Serial Number

No 97465217

Mark Type

No Service/Collective Mark

Attorney Docket Number

No FP2023uspto

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

01.15.15 -

Flames emanating from objects, numbers or words

27.01.04 -

Letters or numerals, including punctuation, forming representations of objects, parts of objects, or maps

Legal History


Show more

Status DateAction Taken
22nd Mar 2024ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
22nd Mar 2024ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
29th Nov 2023FINAL REFUSAL WRITTEN
29th Nov 2023FINAL REFUSAL E-MAILED
29th Nov 2023NOTIFICATION OF FINAL REFUSAL EMAILED
31st Oct 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
31st Oct 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
31st Oct 2023TEAS/EMAIL CORRESPONDENCE ENTERED
02th Aug 2023NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
01st Aug 2023USE AMENDMENT ACCEPTED